down arrow

Guangdong Hybribio Biotech Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002N51
CNY
5.93
0.07 (1.19%)

Dec 05

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Guangdong Hybribio Biotech Co., Ltd.
Why is Guangdong Hybribio Biotech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -4.89% and Operating profit at -227.52% over the last 5 years
2
The company has declared Negative results for the last 9 consecutive quarters
  • NET PROFIT(HY) At CNY -424.31 MM has Grown at -823.3%
  • OPERATING CASH FLOW(Y) Lowest at CNY 189.84 MM
  • ROCE(HY) Lowest at -15.11%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -6.99%, its profits have fallen by -543.5%
  • At the current price, the company has a high dividend yield of 0
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -6.99% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Guangdong Hybribio Biotech Co., Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Guangdong Hybribio Biotech Co., Ltd.
-100.0%
0.41
40.58%
China Shanghai Composite
15.19%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-4.89%
EBIT Growth (5y)
-227.52%
EBIT to Interest (avg)
47.61
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.33
Tax Ratio
14.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.34%
ROE (avg)
16.32%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.93
EV to EBIT
-3.30
EV to EBITDA
-4.34
EV to Capital Employed
0.91
EV to Sales
3.94
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-27.44%
ROE (Latest)
-24.80%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -27.94% (YoY

PRE-TAX PROFIT(Q)

At CNY -44.46 MM has Grown at 78.75%

NET PROFIT(Q)

At CNY -27.3 MM has Grown at 83.43%

-26What is not working for the Company
NET PROFIT(HY)

At CNY -424.31 MM has Grown at -823.3%

OPERATING CASH FLOW(Y)

Lowest at CNY 189.84 MM

ROCE(HY)

Lowest at -15.11%

DEBT-EQUITY RATIO (HY)

Highest at -13.82 %

NET SALES(Q)

Lowest at CNY 132.28 MM

Here's what is working for Guangdong Hybribio Biotech Co., Ltd.
Pre-Tax Profit
At CNY -44.46 MM has Grown at 78.75%
over average net sales of the previous four periods of CNY -209.22 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
At CNY -27.3 MM has Grown at 83.43%
over average net sales of the previous four periods of CNY -164.73 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Raw Material Cost
Fallen by -27.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Guangdong Hybribio Biotech Co., Ltd.
Net Sales
At CNY 132.28 MM has Fallen at -34.21%
over average net sales of the previous four periods of CNY 201.08 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Operating Cash Flow
Lowest at CNY 189.84 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales
Lowest at CNY 132.28 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Debt-Equity Ratio
Highest at -13.82 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."